WPC
BIOL

White Pine Capital’s Biolase, Inc. BIOL Stock Holding History

White Pine Capital’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-70
Closed -$73K – 243
2020
Q4 		$73K Buy
+70
New +$53.4K 0.03% 223
2020
Q2 		– Sell
-257
Closed -$241K – 219
2020
Q1 		$241K Buy
257
+5
+2% +$7.77K 0.12% 161
2019
Q4 		$348K Buy
+252
New +$388K 0.14% 165

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DA
DCM Advisors New York $220M AUM 23.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

White Pine Capital's BIOL Position: Q1 2021 in Review

White Pine Capital sold out of Biolase, Inc. (BIOL) in Q1 2021, closing a stake of 70 shares — an estimated $73K sold.

White Pine Capital first reported a position in BIOL in Q4 2019 and held it in 3 quarters. The position peaked at $348K in Q4 2019. 32 funds tracked by Wall St. Rank hold BIOL as of Q1 2021.

  • White Pine Capital reported no remaining Biolase, Inc. position as of Q1 2021 after selling out during the quarter.
  • White Pine Capital sold 70 Biolase, Inc. shares in Q1 2021, an estimated $73K.
  • White Pine Capital first reported a position in Biolase, Inc. in Q4 2019 and held it in 3 quarters.
  • White Pine Capital's Biolase, Inc. position peaked at $348K in Q4 2019.
  • 32 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2021.

Based on White Pine Capital's 13F filing for Q1 2021, filed 12 May 2021.